Change of the Board of Directors in Probi
Annika Espander, Member of the Board of Directors in Probi since 2009, will join Svenska Handelsbanken as Head of Private Banking from October 1st. In relation to this, Annika Espander resigns from all her external board assignments and she leaves the Probi board as per September 30th.
A new member of the board will be assigned at the annual general meeting in 2011.
For more information, please contact:
Per Lundin, Chairman of the Board, mobile: +46 70 5741171, e-mail: email@example.com
Michael Oredsson, CEO, phone +46 46 286 89 23, mobile: +46 70 718 89 30, e-mail: firstname.lastname@example.org
Probi is a leading player in the probiotic research and the development of efficient and well-documented probiotics.
The research areas include: gastrointestinal tracts, immune system, metabolic syndrome and stress and recovery. Probi’s customers are leading companies in the functional foods and dietary supplement business areas. Total income for 2009 was MSEK 65.5, of which the majority represented royalties. Probi’s share is listed on the Nasdaq OMX Stockholm, Small Cap. Probi has approximately 4,500 shareholders. For more information, please visit www.probi.com.